Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Acta Neuropathologica|May 2, 2022
ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significanceAniello Federico, Christian Thomas, Katarzyna Miskiewicz, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2020
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX MutationsOlivera Casar-Borota, Henning Bünsow Boldt, Britt Edén Engström, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Acta Neuropathologica|November 23, 2024
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsJelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2025
Childhood Cancer Predisposition and Evolutionary Constraints: Novel lessons from Germline Genomes from 1,127 Children with CancerUlrik Kristoffer Stoltze, Thomas van Overeem Hansen, Jon Foss-Skiftesvik, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Pageof 14